DK0399631T3 - Anvendelsen af gestoden til fremstilling af lægemidler - Google Patents

Anvendelsen af gestoden til fremstilling af lægemidler

Info

Publication number: DK0399631T3
Authority: DK; Denmark
Prior art keywords: beta; gestod; drugs; manufacture; estradien
Prior art date: 1989-05-17

Application number

DK90250128.7T

Other languages

Danish (da)

English (en)

Inventor

David Dr Henderson

Michael Prof Baum

Anthony Adrian Dr Colletta

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-17

Filing date

1990-05-17

Publication date

1994-06-06

1990-05-17 Application filed by Schering Ag filed Critical Schering Ag

1994-06-06 Application granted granted Critical

1994-06-06 Publication of DK0399631T3 publication Critical patent/DK0399631T3/da

Links

239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 abstract 2
206010006187 Breast cancer Diseases 0.000 abstract 1
208000026310 Breast neoplasm Diseases 0.000 abstract 1
201000009030 Carcinoma Diseases 0.000 abstract 1
102000009618 Transforming Growth Factors Human genes 0.000 abstract 1
108010009583 Transforming Growth Factors Proteins 0.000 abstract 1
229940046836 anti-estrogen Drugs 0.000 abstract 1
230000001833 anti-estrogenic effect Effects 0.000 abstract 1
201000008275 breast carcinoma Diseases 0.000 abstract 1
239000000328 estrogen antagonist Substances 0.000 abstract 1
229960005352 gestodene Drugs 0.000 abstract 1
230000012010 growth Effects 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
150000003431 steroids Chemical class 0.000 abstract 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK90250128.7T 1989-05-17 1990-05-17 Anvendelsen af gestoden til fremstilling af lægemidler DK0399631T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3916381A DE3916381A1 (de)	1989-05-17	1989-05-17	Verwendung von gestoden zur herstellung von arzneimitteln

Publications (1)

Publication Number	Publication Date
DK0399631T3 true DK0399631T3 (da)	1994-06-06

Family

ID=6381002

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90250128.7T DK0399631T3 (da)	1989-05-17	1990-05-17	Anvendelsen af gestoden til fremstilling af lægemidler

Country Status (15)

Country	Link
EP (1)	EP0399631B1 (de)
JP (1)	JPH0386826A (de)
CN (1)	CN1047298A (de)
AT (1)	ATE101519T1 (de)
AU (1)	AU640139B2 (de)
CA (1)	CA2016895A1 (de)
DD (1)	DD298883A5 (de)
DE (2)	DE3916381A1 (de)
DK (1)	DK0399631T3 (de)
ES (1)	ES2062312T3 (de)
HU (1)	HUT54501A (de)
IE (1)	IE65717B1 (de)
IL (1)	IL94417A (de)
PT (1)	PT94051B (de)
ZA (1)	ZA903803B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
FR2833837B1 (fr) *	2001-12-21	2005-08-05	Oreal	Composition pour la teinture d'oxydation des fibres keratiniques comprenant un amide d'acide gras de colza oxyethylene
JP4775563B2 (ja) *	2006-03-31	2011-09-21	Ｎｏｋ株式会社	センターベアリングサポート
JP2009078123A (ja)	2007-09-07	2009-04-16	Morito Co Ltd	取付部品と取付対象物との連結方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0310542B1 (de) *	1987-10-01	1994-06-08	Schering Aktiengesellschaft	Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren

1989
- 1989-05-17 DE DE3916381A patent/DE3916381A1/de not_active Withdrawn
1990
- 1990-05-16 HU HU903055A patent/HUT54501A/hu unknown
- 1990-05-16 CA CA002016895A patent/CA2016895A1/en not_active Abandoned
- 1990-05-16 PT PT94051A patent/PT94051B/pt not_active IP Right Cessation
- 1990-05-16 IL IL9441790A patent/IL94417A/en not_active IP Right Cessation
- 1990-05-17 ZA ZA903803A patent/ZA903803B/xx unknown
- 1990-05-17 IE IE177590A patent/IE65717B1/en not_active IP Right Cessation
- 1990-05-17 DD DD90340770A patent/DD298883A5/de not_active IP Right Cessation
- 1990-05-17 DE DE69006633T patent/DE69006633T2/de not_active Expired - Lifetime
- 1990-05-17 AU AU55135/90A patent/AU640139B2/en not_active Ceased
- 1990-05-17 AT AT90250128T patent/ATE101519T1/de not_active IP Right Cessation
- 1990-05-17 JP JP2125615A patent/JPH0386826A/ja active Pending
- 1990-05-17 EP EP90250128A patent/EP0399631B1/de not_active Expired - Lifetime
- 1990-05-17 CN CN90103702A patent/CN1047298A/zh active Pending
- 1990-05-17 DK DK90250128.7T patent/DK0399631T3/da active
- 1990-05-17 ES ES90250128T patent/ES2062312T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU5513590A (en)	1990-11-29
ES2062312T3 (es)	1994-12-16
ZA903803B (en)	1991-03-27
DE3916381A1 (de)	1990-11-22
CA2016895A1 (en)	1990-11-17
DE69006633D1 (de)	1994-03-31
EP0399631B1 (de)	1994-02-16
DD298883A5 (de)	1992-03-19
DE69006633T2 (de)	1994-08-25
JPH0386826A (ja)	1991-04-11
IE65717B1 (en)	1995-11-15
IE901775L (en)	1990-11-17
AU640139B2 (en)	1993-08-19
EP0399631A1 (de)	1990-11-28
PT94051A (pt)	1991-01-08
IL94417A (en)	1995-07-31
HU903055D0 (en)	1990-09-28
HUT54501A (en)	1991-03-28
CN1047298A (zh)	1990-11-28
ATE101519T1 (de)	1994-03-15
IL94417A0 (en)	1991-03-10
PT94051B (pt)	1996-11-29

Similar Documents

Publication	Publication Date	Title
ATE84412T1 (de)	1993-01-15	Pharmazeutisches praeparat mit verzoegerter abgabe eines dihydropyridins und eines betaadrenorezeptor-antagonisten und herstellungsverfahren dessen.
IT8123070A0 (it)	1981-07-22	Preparato che favorisce la coagulazione del sangue a base di proteine umani, nonche'procedimento per la preparazione
HUT66437A (en)	1994-11-28	A composition used as a therapeutic agent against chronic viral hepatic diseases
BG42837A3 (bg)	1988-02-15	Метод за получаване на имуноглобулинови производни на винка алкалоиди
DE68915503D1 (de)	1994-06-30	Zahnchirurgisches Gerät, geeignet für die Versorgung von gekoppelten Handstücken mit drei unterschiedlichen Fluida.
BG60324B2 (en)	1994-07-25	New somatotropines
DK0416678T3 (da)	1993-12-20	Topiske præparater indeholdende Defibrotid
FI874166A7 (fi)	1988-03-25	2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
EP0424156A3 (en)	1992-04-22	Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
ES2062312T3 (es)	1994-12-16	Uso de gestodeno para la produccion de agentes farmaceuticos.
NZ222434A (en)	1990-06-26	Tissue factor protein lacking its naturally associated phospholipid
SE8900875D0 (sv)	1989-03-13	Osteoporosis treatment
NO901631D0 (no)	1990-04-10	Fremgangsmaate for fremstilling av 2-substituerte n,n'-ditrimetoksybenzoyl-piperaziner.
DE69943239D1 (de)	2011-04-14	Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DE69032000D1 (de)	1998-03-05	Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DK99987A (da)	1987-08-28	Oestrogenpraeparater
DE69023459D1 (de)	1995-12-14	Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ZA872128B (en)	1987-11-25	Chlorpheniramine therapy
DE3380923D1 (de)	1990-01-11	Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
ZA849576B (en)	1985-08-28	1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
PT74794A (en)	1982-05-01	Process for preparing oxazole derivatives
DE3273979D1 (en)	1986-12-04	9,10-substituted 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isoquinolin-4-ones, process for their preparation and their use as medicaments
ATE82128T1 (de)	1992-11-15	Pharmazeutische zusammensetzungen zur behandlung von krebs.
IT8323811A0 (it)	1983-11-22	Poltrona medicale specialmente odontoiatrica dorata di una parte imbottita.
GR3019441T3 (en)	1996-06-30	Use of (1R,2R)-N-methyl-2-(3-pyridyl)2-tetrahydrothiopyran-carbothioamide-1-oxide for the preparation of medicaments for the treatment of coronary insufficiency